Provident CO Of The Employees Of The Hebrew University LTD Biogen Inc. Transaction History
Provident CO Of The Employees Of The Hebrew University LTD
- $84 Billion
- Q2 2024
A detailed history of Provident CO Of The Employees Of The Hebrew University LTD transactions in Biogen Inc. stock. As of the latest transaction made, Provident CO Of The Employees Of The Hebrew University LTD holds 4,643 shares of BIIB stock, worth $809,739. This represents 1.28% of its overall portfolio holdings.
Number of Shares
4,643
Previous 4,631
0.26%
Holding current value
$809,739
Previous $999 Million
7.73%
% of portfolio
1.28%
Previous 1.06%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,017Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$2.9 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.85 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.54 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.24 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$990 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $25.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...